4.7 Article

Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice

Journal

DIABETOLOGIA
Volume 57, Issue 4, Pages 801-808

Publisher

SPRINGER
DOI: 10.1007/s00125-013-3148-x

Keywords

Glucagon clearance; Glucagon kinetics; Population analysis

Funding

  1. Women in Science and Engineering Undergraduate Research Fellowship from Univ. of Southern California to AZ (DZD mentor)
  2. National Institutes of Health [P41-EB001978]
  3. Swedish Research Council [6834]
  4. Region Skane and Faculty of Medicine, Lund University

Ask authors/readers for more resources

Aims/hypothesis Given the importance of glucagon in the development of type 2 diabetes and as a potential therapeutic agent, the aim of this study was to characterise glucagon kinetics in mice and its regulation by the nutritional state. Methods Anaesthetised C57BL/6 mice fed normal or high-fat diets, or fasted, were injected intravenously with glucagon (0.1, 0.3, 1.0, 10.0 or 20 mu g/kg); blood samples were withdrawn before injection and 1, 3, 5, 10, 20 min thereafter for glucagon assay by RIA. Glucagon kinetics were described by two-compartment models using a population analysis. Results The population mean and between-animal SD of glucagon clearance in the fed mice was 6.03 +/- 2.58 ml/min, with a rapid elimination half-life of 2.92 +/- 1.21 min. Fasted mice showed a slower glucagon clearance. The kinetics of glucagon in the fed and fasted group was linear across this large dose range. The mice fed a high-fat diet, however, showed non-linear kinetics with a faster terminal clearance of 20.4 +/- 5.45 ml/min (p < 0.001) and a shorter elimination half-life of 1.59 +/- 0.606 (p < 0.001) min relative to normal mice. Conclusions/interpretation This first systematic dose-ranging study of glucagon kinetics produced several findings: (1) a linear two-compartment model describes glucagon in normal C57BL/6 mice; (2) fasting reduces the clearance of glucagon and (3) high-fat diet enhances the clearance of glucagon. These results may direct future studies on glucagon physiology and indicate that there are other mechanisms, not included in the current model, needed to fully explain glucagon's kinetics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Physiology

Human insulin dynamics in women: a physiologically based model

Michael Weiss, Andrea Tura, Alexandra Kautzky-Willer, Giovanni Pacini, David Z. D'Argenio

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)

Article Infectious Diseases

Population-based meta-analysis of roxithromycin pharmacokinetics: dosing implications of saturable absorption and protein binding

Michael J. Dolton, David Z. D'Argenio

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Article Immunology

Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a

Karen M. Gallegos, George L. Drusano, David Z. D'Argenio, Ashley N. Brown

JOURNAL OF INFECTIOUS DISEASES (2016)

Article Biochemistry & Molecular Biology

Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice

Gina Song, Giovanni Pacini, Bo Ahren, David Z. D'Argenio

PEPTIDES (2017)

Article Microbiology

Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis

A. Young J. Park, Joshua Wang, Jordanna Jayne, Lynn Fukushima, Adupa P. Rao, David Z. D'Argenio, Paul M. Beringer

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Pharmacology & Pharmacy

A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor

Wenbo Chen, Britton Boras, Tae Sung, Yanke Yu, Jenny Zheng, Diane Wang, Wenyue Hu, Mary E. Spilker, David Z. D'Argenio

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2020)

Article Pharmacology & Pharmacy

Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling

Shihao Hu, David Z. D'Argenio

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2020)

Article Physiology

Biokinetic modeling of nanoparticle interactions with lung alveolar epithelial cells: uptake, intracellular processing, and egress

Wenbo Chen, David Z. D'Argenio, Arnold Sipos, Kwang-Jin Kim, Edward D. Crandall

Summary: Studies on the health effects of engineered nanomaterials in the lung have shown that inhaled nanoparticles can partially cross the air-blood barrier, enter the vasculature, and distribute to various organs. Experiments with polystyrene nanoparticles in a rat alveolar epithelial cell model demonstrated that the particles are taken up by cells through nonendocytic processes, triggering autophagy and subsequently being exocytosed through lysosomes. These findings suggest complex regulatory mechanisms involving internalization, autophagy, lysosomal exocytosis, and cellular processing of nanoparticles.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2021)

Article Biochemistry & Molecular Biology

Characteristics of Passive Solute Transport across Primary Rat Alveolar Epithelial Cell Monolayers

Yong Ho Kim, Kwang-Jin Kim, David Z. D'Argenio, Edward D. Crandall

Summary: The study found that passive diffusion of hydrophilic solutes across rat alveolar epithelial cells occurs through small and large equivalent pores, reflecting interactions of transmembrane proteins expressed in the intercellular tight junctions of the cells.

MEMBRANES (2021)

Article Medicine, Research & Experimental

Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties

Shihao Hu, Amita Datta-Mannan, David Z. D'Argenio

Summary: A model-based framework is presented to predict the pharmacokinetics of monoclonal antibodies in humans using in vitro measures of antibody physiochemical properties. The study found a positive correlation between nonspecific binding and antibody-specific vascular to endothelial clearance, as well as a correlation between heparin relative retention time and antibody paracellular transport.
Article Medical Laboratory Technology

Population Pharmacokinetic Modeling of Vancomycin in Thai Patients With Heterogeneous and Unstable Renal Function

Siriluk Jaisue, Cholatip Pongsakul, David Z. D'Argenio, Pakawadee Sermsappasuk

THERAPEUTIC DRUG MONITORING (2020)

Article Pharmacology & Pharmacy

Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony-Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation

Wenbo Chen, Britton Boras, Tae Sung, Wenyue Hu, Mary E. Spilker, David Z. D'Argenio

AAPS JOURNAL (2020)

Article Clinical Neurology

The Efficiency, Efficacy, and Retention of Task Practice in Chronic Stroke

Chunji Wang, Carolee Winstein, David Z. D'Argenio, Nicolas Schweighofer

NEUROREHABILITATION AND NEURAL REPAIR (2020)

Article Microbiology

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis

Timothy J. Bensman, Joshua Wang, Jordanna Jayne, Lynn Fukushima, Adupa P. Rao, David Z. D'Argenio, Paul M. Beringer

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Article Genetics & Heredity

RAD-ADAPT: Software for modelling clonogenic assay data in radiation biology

Yaping Zhang, Kaiqiang Hu, Jan H. Beumer, Christopher J. Bakkenist, David Z. D'Argenio

DNA REPAIR (2017)

No Data Available